Skip to main content
. 2008 May 26;2:265–280. doi: 10.4137/bbi.s665

Table 2.

Overview of all contrasts included in the explorative meta-analysis.

Contrast Sample group 1
Sample group 2
Cluster
Genetic background Treatment Genetic background Treatment
GSE1491_1 WT Col-0 IAA WT Col-0 non IAA
GSE1491_2 WT Col-0 IAA inhibitor A WT Col-0 non IAA
GSE1491_3 WT Col-0 IAA inhibitor B WT Col-0 non IAA
GSE1491_4 WT Col-0 IAA/IAA inhibitor A WT Col-0 non IAA
GSE1491_5 WT Col-0 IAA/IAA inhibitor B WT Col-0 non IAA
GSE3959_1 MU LEC2GR 1h LEC2 induction MU LEC2GR non other
GSE3959_2 MU LEC2GR 4h LEC2 induction MU LEC2GR non other
GSE3959_3 MU LEC2GR 1h LEC2 induction WT WS-0 4h LEC2 induction other
GSE3959_4 MU LEC2GR 4h LEC2 induction WT WS-0 4h LEC2 induction other
GSE431_1 pmr4-1 MU non pmr4-1 MU powdery mildew pathogen
GSE4662_1 MU STA1 non WT NA other
GSE5465_2 MU OETOP6B non WT NA other
GSE5520_1 WT Col-0 DC1318 Cor 10e6 MU STA1 non pathogen
GSE5520_10 WT Col-0 EcTUV86-2 fliC 10e8 WT Col-0 non pathogen
GSE5520_3 WT Col-0 DC3000 10e6 WT Col-0 non pathogen
GSE5520_5 WT Col-0 DC1318 Cor 5×10e7 WT Col-0 non pathogen
GSE5520_6 WT Col-0 DC3000 hrpA-fliC 10e8 WT Col-0 non pathogen
GSE5520_7 WT Col-0 DC3000 hrpA 10e8 WT Col-0 non pathogen
GSE5520_9 WT Col-0 EcO157H7 10e8 WT Col-0 non pathogen
GSE5526_1 WT? non WT? non other
GSE5759_1 WT Col-0 dark plus lincomycin WT Col-0 dark other
GSE5759_2 WT Col-0 red light plus lincomycin WT Col-0 red light other
GSE5770_1 WT Col-0 lincomycin WT Col-0 non other
GSE5770_2 MU abi4-102 lincomycin MU abi4-102 non other
GSE5770_3 MU gun1-1 lincomycin MU gun1-1 non other
GSE630_1 WT Col-0 IAA (2h 5 μM) WT Col-0 EtOH (2h) IAA
GSE630_10 MU arf2-6 IAA (2h 5 μM) MU arf2-6 EtOH (2h) IAA
GSE630_17 MU IAA17-6 EtOH (2 h) WT Col-0 I EtOH (2h) IAA
GSE630_18 MU arx3-1 EtOH (2 h) WT Col-0 I EtOH (2h) IAA
GSE630_19 MU i5i6i19 EtOH (2 h) WT Col-0 I EtOH (2h) IAA
GSE630_2 MU nph4-1 IAA (2h 5 μM) MU nph4-1 EtOH (2h) IAA
GSE630_20 MU IAA17-6 IAA (2h 5 μM) WT Col-0 I IAA (2h 5μM) IAA
GSE630_21 MU arx3-1 IAA (2h 5 μM) WT Col-0 I IAA (2h 5μM) IAA
GSE630_22 MU i5i6i19 IAA (2h 5 μM) WT Col-0 I IAA (2h 5μM) IAA
GSE630_24 MU arf2-6 IAA (2h 5 μM) WT Col-0 A2 IAA (2h 5μM) IAA
GSE630_3 MU arf19-1 IAA (2h 5 μM) MU arf19-1 EtOH (2h) IAA
GSE630_6 MU IAA17-6 IAA (2h 5 μM) MU IAA17-6 EtOH (2h) IAA
GSE630_8 MU i5i6i19 IAA (2h 5 μM) MU i5i6i19 EtOH (2h) IAA
GSE631_2 MU arf2-6 IAA (2h 5 μM) MU arf2-6 non IAA
GSE631_4 MU arf2-6 IAA (2h 5 μM) WT Col-0 IAA (2h 5μM) IAA
GSE911_4 35S::LFY non WT ler 35S::LFY other

Each contrast consists of two groups which are described by their genetic background and treatment. The last column cluster derives from the clustering on the kernel PCA scores. Contrasts are labeled with the GEO series number followed by a contrast index.